2020 HIDA Influenza Vaccine Production And Distribution Market Report

The 2020-2021 flu season will be the first full influenza season coinciding with the COVID-19 pandemic, creating concerns of potential coinfections and overwhelmed hospitals. The 2020 HIDA Influenza Vaccine Production & Distribution Market Report provides insights into the upcoming flu season including: the impact of COVID-19, vaccine makeup, vaccine effectiveness, and reimbursement. Insights include:

  • COVID-19 spurs production of approximately 15% more flu vaccine doses
  • Flu vaccination prevented 105,000 hospitalizations and 6,300 deaths in 2019-2020
  • 52% of Americans received a vaccine last season; experts this year target a 70% vaccination rate

Purchase a PDF license for your entire team allowing unlimited distribution within your company.

Single download for members: Free | Non-members: $50

License price for members: $1550 | Non-members: $1550

Contact:

Kathleen Fox, PhD»
Manager, Business Intelligence
HIDA, 703-838-6108